Commentaries
To (anti-)TNF or not (anti-)TNF? That is the question in pemphigus
First published: 16 March 2015
No abstract is available for this article.
References
- 1Langan SM, Smeeth L, Hubbard R et al. Bullous pemphigoid and pemphigus vulgaris – incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: a180.
- 2Martin LK, Werth V, Villanueva E et al. Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2009; 1: CD006263.
- 3Martin LK, Werth VP, Villaneuva EV, Murrell DF. A systematic review of randomized controlled trials for pemphigus vulgaris and pemphigus foliaceus. J Am Acad Dermatol 2011; 64: 903–8.
- 4Giordano CN, Sinha AA. Cytokine networks in pemphigus vulgaris: an integrated viewpoint. Autoimmunity 2012; 45: 427–39.
- 5Feliciani C, Toto P, Amerio P et al. In vitro and in vivo expression of interleukin-1alpha and tumor necrosis factor-alpha mRNA in pemphigus vulgaris: interleukin-1alpha and tumor necrosis factor-alpha are involved in acantholysis. J Invest Dermatol 2000; 114: 71–7.
- 6Berookhim B, Fischer HD, Weinberg JM. Treatment of recalcitrant pemphigus vulgaris with the tumor necrosis factor alpha antagonist etanercept. Cutis 2004; 74: 245–7.
- 7Pardo J, Mercader P, Mahiques L et al. Infliximab in the management of severe pemphigus vulgaris. Br J Dermatol 2005; 153: 222–3.
- 8Jacobi A, Shuler G, Hertl M. Rapid control of therapy-refractory pemphigus vulgaris by treatment with the tumour necrosis factor-alpha inhibitor infliximab. Br J Dermatol 2005; 153: 448–9.
- 9Lin MH, Hsu CK, Lee JY. Successful treatment of recalcitrant pemphigus vulgaris and pemphigus vegetans with etanercept and carbon dioxide laser. Arch Dermatol 2005; 141: 680–2.
- 10Shetty A, Marcum CB, Glass LF, Carter JD. Successful treatment of pemphigus vulgaris with etanercept in four patients. J Drugs Dermatol 2009; 8: 940–3.
- 11Hall RP, Fairley J, Woodley D et al. A multicentre randomized trial of the treatment of patients with pemphigus vulgaris with infliximab and prednisone compared with prednisone alone. Br J Dermatol 2015; 172: 760–68.
